Our blog

May Biotech Insights: Key Discoveries 2025
May Biotech Insights: Key Discoveries 2025
by Katie Davis
Posted in Life Science & Diagnostics
Head-hunter Katie Davis is consistently keeping up to date with the latest news within the biotech industry. From funding to collaborations, acquisitions, product and legal updates, in this blog we explore the latest funding updates throughout the month of May.
Read more
Biotech Funding Rounds and Key Findings | March
Biotech Funding Rounds and Key Findings | March
by Katie Davis
Posted in Biopharma, Life Science & Diagnostics
Head-hunter Katie Davis is consistently keeping up to date with the latest news within the biotech industry. In this blog, we explore the latest funding updates throughout the month of March.
Read more
Biotech Funding Q4 2024
Biotech Funding Q4 2024
by Katie Davis
Posted in Life Science & Diagnostics
Head-hunter Katie Davis is consistently keeping up to date with the latest news within the biotech industry. In this blog, we explore the latest funding updates throughout Q4 2024.
Read more
Biotech Funding Rounds and Key Findings | February
Biotech Funding Rounds and Key Findings | February
by Katie Davis
Posted in Life Science & Diagnostics
Head-hunter Katie Davis is consistently keeping up to date with the latest news within the biotech industry. In this blog, we explore the latest funding updates throughout the month of February.
Read more
January Biotech Insights: Key Discoveries 2025
January Biotech Insights: Key Discoveries 2025
by Katie Davis
Posted in Life Science & Diagnostics
Head-hunter Katie Davis is consistently keeping up to date with the latest news within the biotech industry, whether that be funding news, acquisitions, spin outs and expansions, legal updates, layoffs and restructuring, collaborations or general product updates. In this blog, we explore the latest updates throughout the month of January.
Read more
Biotech Funding Throughout Q4 2024 | Seed to Series A-E
Biotech Funding Throughout Q4 2024 | Seed to Series A-E
by Katie Davis
Posted in Biopharma
Life Science Head-hunter Katie Davis is consistently keeping up to date with the latest news within the biotech industry. In this blog, we explore the latest updates throughout Q4 2024 - from funding through to market updates.
Read more
IPO Momentum in Biotech: What Does it Mean for Companies and Talent in 2025?
IPO Momentum in Biotech: What Does it Mean for Companies and Talent in 2025?
by Katie Davis
Posted in Biopharma, Life Science & Diagnostics
Across the life sciences market, IPOs are more than just fundraising —they are indicators of investor confidence and market potential. After a slowdown in recent years, IPO activity is picking up pace again in 2025, particularly within biotech. In this blog, Katie Davis explores the latest trends.
Read more
Biotech Funding Rounds and Key Findings | September
Biotech Funding Rounds and Key Findings | September
by Katie Davis
Posted in Life Science & Diagnostics
Head-hunter Katie Davis is consistently keeping up to date with the latest news within the biotech industry. In this blog, we explore the latest funding updates throughout the month of September.
Read more